No registrations found.
ID
Source
Health condition
Hypertension; (health) literacy
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameter is change in blood pressure
control between baseline and the first standard control measurement compared between the control and intervention group.
Secondary outcome
Participants’ use of the leaflet and their perceived comprehensibility, utility and design quality of the leaflet, as well as their recall and understanding of information, self-efficacy, intention to adhere and self-reported adherence will be assessed in the interview and represented by scores that will be compared
between the control and intervention group.
Study objective
We expect that, compared to a standard text-only, a leaflet with pictograms leads to better perceived comprehensibility, utility and design quality of the leaflet
by consumers. This could lead to better recall and understanding of the drug information, increasing patients’ self-efficacy, and in turn intention to adhere and actual adherence, which could lead to better blood pressure control. Additionally, we aim to gain insight into the
question as to whether such intervention is especially beneficial for low-literate people, who are not sufficiently helped with a text-only leaflet format.
Study design
Blood pressure control means that the patient has achieved the target blood pressure that was set out by their treating physician. Values at baseline (last measurement by HCP before first prescription of
antihypertensive drugs) will be compared to blood pressure measurements of the first routine check-up (usually three weeks after start of medication).
The secondary outcomes will be measured during two interviews - one at t=2-3 weeks and one at t=4-5 weeks after the patients have received the leaflet in the pharmacy.
Intervention
The control group will receive a secondary patient information leaflet that is text-only; the intervention group will receive the same information with pictograms added.
M.M. van Beusekom
Sylviusweg 72
Leiden 2333 BE
The Netherlands
071 527 1886
m.m.van_beusekom@lumc.nl
M.M. van Beusekom
Sylviusweg 72
Leiden 2333 BE
The Netherlands
071 527 1886
m.m.van_beusekom@lumc.nl
Inclusion criteria
Adult patients who get prescribed antihypertensive medication for the first time, or for the first time after at least a year of not having received this medication.
Exclusion criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study:
- unable to verbally communicate in Dutch
- blind
- under 18 years of age
- incapacitated
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL5593 |
NTR-old | NTR5699 |
Other | : P15.209 |